Delivery Order SPE2DR25D1100-SPE2DR26FCV2J
Award Date 12/16/25
Potential Completion Date 12/17/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,570.63 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of August 12, 2025. This non-set-aside, firm fixed-price contract was competitively awarded on August 11, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. Orencia (abatacept) is a biologic immunosuppressant used primarily to treat rheumatoid arthritis and other autoimmune conditions, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $6,365.41 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on November 25, 2025, with completion scheduled for November 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant used primarily in the treatment of rheumatoid arthritis...
- The Defense Logistics Agency awarded a $28,798.84 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on December 5, 2025, with an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $8,215.15 to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $8,602.31 on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $20,773.97 on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $7,141.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on September 29, 2025, with completion scheduled for September 30, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a $8,363.88 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes. This is a firm fixed price, non-set-aside contract awarded on December 8, 2025, with an ultimate completion date of December 9, 2025. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune conditions, making...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Orencia 125 mg/ml syringes valued at $14,495.04. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $11,739.22 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed price contract with no set-aside designation, executed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic disease-modifying antirheumatic drug used to treat rheumatoid arthritis and other autoimmune...